Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloprost inhalation before and during extracorporeal circulation in high-risk cardiac surgery
2008-002090-12Phase 3Completed
- Sponsor
- LMU Klinikum
- Start
- Nov 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cardiopulmonary morbidity, pulmonary arterial hypertension (PAH) and cardiac morbidity comparing Iloprost (Ventavis) inhalation with Placebo inhalation (2 arms). Primary endpoint: Duration of postoperative artificial respiration. Started Nov 2008; status: completed.
02
Drugs
iloprost
03
Conditions
Cardiopulmonary morbiditypulmonary arterial hypertension (PAH)cardiac morbidity
Beyond the preview
Go deeper on 2008-002090-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002090-12.